It is now critical to understand HIMS' legal pathway to selling personalized doses since it has to be the primary mechanism to sell semaglutide going forward," the Leerink Partners analysts wrote
He holds a Bachelor of Science and Master of Science in Industrial and Systems Engineering from the University of Wisconsin-Madison, and a doctorate in Systems and Industrial Engineering from the University of Arizona.
It just depends on each provincial review of whether they include it or dont include it as part of their drug benefits for people who are eligible for the drug benefit program. Small also added that it makes sense economically to include generic GLP-1 drugs into insurance plans
GLP-1 receptor agonists stimulate insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through multiple physiological pathways
Adherence is just the beginning
As GLP-1 receptor agonists become more widely used, physicians can better identify adverse reactions, including systemic hypersensitivity responses
